Figure 1

![Figure 1: Body weight changes and disease activity indices in the colitis model are compared between Bifidobacterium lactis BL-99-treated and control groups, indicating protective effects of probiotic supplementation.]()

> Source: Meng Chen et al. "Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in ." *PloS one*, 2022. PMID: [35171916](https://pubmed.ncbi.nlm.nih.gov/35171916/)

<figure>
  <img src="" alt="Body weight changes and disease activity indices in the colitis model are compared between Bifidobacterium lactis BL-99-treated and control groups, indicating protective effects of probiotic supplementation." />
  <figcaption>Figure 1. Body weight changes and disease activity indices in the colitis model are compared between Bifidobacterium lactis BL-99-treated and control groups, indicating protective effects of probiotic supplementation.<br>  Source: Meng Chen et al. "Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in ." <em>PloS one</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35171916/">35171916</a></figcaption>
</figure>